Escolar Documentos
Profissional Documentos
Cultura Documentos
Abstract
Mental disorders can be conceptualized as
extreme manifestations of behavioural dimensions.
However, most experimental animal researches does
not encompass this dimensional aspect since they
consist in reproducing one or several specific
symptoms by specific experimental manipulations. A
promising alternative is to model human behavioural
dimensions based on behavioural traits or capacities
existing spontaneously in rats. The purpose of this
chapter is to show that selecting animals exhibiting
Correspondence/Reprint request: Dr. Franoise Dellu-Hagedorn, Universit Bordeaux 2; Universit Bordeaux 1
CNRS; UMR 5227, 146 rue Lo Saignat BP 31, 33076 Bordeaux cedex, France
E-mail: francoise.dellu@lnpb.u-bordeaux2.fr
Introduction
Due to the influence of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV), psychopathologies are usually conceptualized as
categories with the assumption that there are clear boundaries delineating
disorders and normality. However, this classification is now questioned and
one of the major goals of the future classification (DSM-V) is to take into
account that most psychiatric symptoms occur across a continuum and can be
conceptualized as extreme manifestations of behavioural dimensions. Thus, a
dimensional approach could more closely conform to clinical reality.
No animal model can ever fully mirror the human situation [53], and one has
to keep in mind that similar behaviours may have different meanings [101].
However, progress in biomedical therapy closely depends on animal models and
it is a challenge to establish models of behavioural perturbations similar to those
observed clinically. Most neuroscientific experimental research using animal
models does not encompass a dimensional view as they consist in reproducing
one or several specific symptoms by experimental manipulations (e.g. surgical
lesioning, genetic, pharmacologic, environmental) and then comparing them with
normal control conditions. The main difficulty with such models is that these
manipulations induce readaptations, and the extent to which they interact with
other neuroanatomic activity, neurochemistry, synaptic or genetic plasticity, or in
other behavioural outcomes is often unknown [80]. A promising alternative is to
model human behavioural dimensions based on spontaneous individual
differences in animals behaviour. Selecting spontaneously extreme or
maladapted behaviours broadens the relevance of the model, notably for the
search of endophenotypes, as no particular hypothesis is established about their
origins. In neurobiological research, inter-individual differences in animal
behaviour are usually considered as a random and uncontrollable phenomenon.
The main criticism is that considering animals as an individual reflects
anthropomorphic projections. However, studies on inter-individual differences in
behaviour reveal striking similarities in the pattern and structure of behavioural
responses in a wide variety of species, from octopuses and fish to apes and
humans [48,51]. Human and animal personality can be viewed as a system of
stable traits which must be inferred from observed behaviours in various
situations. There is a large literature on animal behavioural disorders. For
example, dogs develop conditions analogous, and possibly homologous, to some
human psychiatric disorders; which may include generalized anxiety disorder,
attachment disorder, panic and aggressive impulse control disorders [80].
Unfortunately, there is no unified body of research on animal personality and
studies are dispersed across multiple disciplines. This is well illustrated by the
impressive review of Gosling, a leader in the field, that summarizes most of the
research that has been published on animal temperament and personality [52].
In neuroscience and cognitive science, the relevance of studying
temperaments and personalities (integrated behavioural phenotypes and
stable traits that are consistent over time and across situations), is under
investigated. The purpose of this chapter is to demonstrate that behavioural
traits or capacities existing spontaneously in rats can be assessed, and that
selecting animals showing extreme or maladapted behaviours is of great
interest to explore their psychobiological particularities. Moreover, the study
of the evolution of these behavioural traits during development and their
long-term consequences on adaptation is much easier than in humans, given
the relatively short life-span of small rodents and the possibility of strict
control of their environment. The relevance of developing animal models of
psychopathology by the means of a differential approach will be illustrated by
research based on impulsivity and sensation-seeking behavioural traits in rats.
Motor impulsivity
Tasks
Choice
FCN8
FI
EXT
Behavioral inhibition
Requirements
Delay discounting task (Choice), Fixed consecutive number schedule of reinforcement (FCN8),
Fixed-interval (FI) and extinction (EXT) schedule of reinforcement (Reprinted from [21] with
permission).
task, demonstrating that impulsive rats lower efficiency was not due to a
learning deficit. Furthermore, the rate of responding on both levers was
higher in non-impulsive rats, probably because of their higher motivation for
performing primarily rewarded chains of presses rather than hyperactivity, a
finding that has been previously reported [24]. This behaviour cannot be
attributed to a decrease in motivation for food reward, given that the latencies
to collect food did not differ.
Motor impulsiveness was tested through two different schedules
measured in a two-component 2-min fixed interval (FI) 5-min extinction
(EXT) schedule of reinforcement (adapted from [12]). This task, that assesses
general behavioural inhibition in two different contexts, has been used to
reveal hyperactivity and impulsiveness in both laboratory and clinical
populations, most notably in the Spontaneous Hyperactive Rat model of
ADHD and in children diagnosed with ADHD [93,110]. During FI, responses
during the time-interval (2 min) have no consequence, but the first response
after the interval has elapsed produces the delivery of a food pellet. The
differences in activity levels between hyperactive vs hypoactive SpragueDawley rats in both FI and EXT schedules were very important, a factor of
10 separated the more and the less active rats (Figure 3). These differences
were approximatively two-times greater than between Spontaneously
Hypertensive and the Wistar Kyoto strains on both schedules, despite a lower
global activity of the Sprague-Dawley strain in this task [93]. These
differences in activity levels are remarkably similar to differences observed
between ADHD children and their controls in a similar protocol [94]. The
reinforcement contingency typically generates a scalloped pattern with
little or no responding early in the interval and a progressive increase in rate
when the opportunity for reinforcement delivery approaches [45]. Temporal
discrimination is probably involved, and excessive lever presses could reflect
over-anticipation of the reward [54], perhaps caused by an over estimation of
time. However, the hyperactivity observed in this task is not only related to
earlier anticipation of reward, but also to higher sustained activity that lasts
throughout the session.
During extinction, the absence of light (which had been paired with the
availability of a reward during the fixed interval session) clearly indicates
that no reinforcement is available. Thus, when the rat continues to press the
lever excessively, this hyperactivity might be considered as a perseverative
behaviour, an aspect of disinhibition reflected by a tendency to pursue a goaldirected behaviour that is no longer appropriate and that might also be related
to poor attentional processes [93].
Whereas, numerous intra-task correlations were evidenced [21], only a
few inter-test relationships were found, strongly suggesting that the
behaviours measured are not underpinned by a unitary process, according to
the literature in human and animals [70,123]. The more significant
correlations obtained concerned measures of similar activities attesting to the
coherence of the measures. For example, activity during extinction periods
was only correlated with total activity in the delay discounting task,
confirming that this measure involves another aspect of motor impulsivity in
which hyperactivity is observed independently of the context. Surprisingly, a
relationship between incapacity to terminate a chain of presses in the FCN8
task and hyperactivity during extinction periods was also observed. This
relationship seems to be driven by some particular rats that cannot extinguish
their activity during extinction periods (see Figure 2C). These rats exhibit a
high level of behavioural disinhibition that is reflected in the FCN8 task,
10
namely they are less disposed to inhibit premature responding. This result is
in line with the hypothesis that extinction deficit could explain response
disinhibition [60].
11
12
Figure 5. Locomotor response to novelty (A) and to saline and amphetamine injection
(s.c. 1mg/kg) (B) of high-responders (HR) and low-responders (LR) to novelty in a
circular corridor. Light contingent lever pressing of LR (C-D) and HR rats (E-F) after
saline or amphetamine injection (i.p. 2 mg/kg). Arrows represent time for saline or
amphetamine injections.
13
Figure 6. Comparisons of locomotor reactivity of rats with low (LOWFCN) and high
(HIGHFCN) levels of inhibition selected in the FCN task in response to saline and
amphetamine injections (1mg/kg i.p.). LOWFCN had a higher locomotor response to
amphetamine compared to HIGHFCN lasting 1h after injection. ANOVA (NK): ***
p<0.001; ** p<0.01, * p<0.05. (Reprinted from [21], with permission).
14
Figure 7. Longitudinal studies of behavioural traits of impulsivity and sensationseeking. A-B: Performances of impulsive rats (LOWFCN) are lower than those of
intermediate (INTFCN) and non-impulsive rats (HIGHFCN) under a FCN8 schedule of
reinforcement, at 6 and 15 months. (adapted from [21]). C: The difference in novelty
reactivity over 2h characterizing HR and LR remains until middle-age and then
disappears with age. D: Dark-light emergence task: the difference in the latency to
emerge from dark to brightly illuminated compartment between HR and LR rats
during youth disappears with aging. E-F: Light-contingent lever-pressing: rats with a
higher self-stimulation of a flashing light (HSS) compared to rats with a low selfstimulation (LSS) still presented a higher rate of stimulation when old. Statistical
significance, ANOVA, ***, p<0.001; **, p<0.01; *, p<0.05. Fig. 7AB reprinted and
partially adapted from [24], Copyright (2008), with permission from Elsevier and
Fig.7C reprinted from [29], Copyright (2008) with permission from S. Karger AG.
15
16
Figure 8. Cognitive performances of middle-aged impulsive (LOWFCN) and nonimpulsive rats (HIGHFCN) characterized in the FCN8 schedule during youth. A:
Time-course of working memory performances of the two groups measured in an 8arm radial-maze. B: After stabilisation of the performances, effect of confinement
duration before a choice was tested on working memory performances. Statistical
analysis: ANOVA, ** p<0.01; * p<0.05. within comparisons: p<0.01. C: Timecourse of place discrimination learning of the two groups in a water-maze. D: Probe
trial (platform omitted): percentage mean time spent by the two groups in a 60 cm
diameter virtual circle around previous position of the platform. Statistical analysis:
t-test: * p<0.05. Fig. 8A-B reprinted and partially adapted from [26,29], Copyright
(2008), with permission from Elsevier.
17
18
19
20
in a circular corridor and in a running-wheel). Only the inattentiveimpulsive subgroup demonstrated hyperactivity, which was expressed in a
cage both during initial and basal activities (Figure 10 C-D). This
hyperactivity could reflect that of ADHD children in low environmental
stimulations: clinical and neuropsychological data in humans indicate that
the expression of hyperactivity in ADHD is related more to a general level
of activity than to an increased locomotion [95,100] and tends to increase in
situations of low environmental stimulation [3,126,127].
21
Conclusions
Psychiatric disorders are among the least well understood, the most
complex and the most incapaciting of all pathological conditions. Given that
psychiatric disorders are solely defined on the basis of their behavioural
particularities, a challenge for biomedical research is to better model their key
symptoms in animal models [38]. Experiments presented here have been
designed to support analogies between behavioral abnormalities in animals
and human traits and pathology. This approach supports our working
hypothesis that individual differences in animal behaviour can reliably
exhibit dimensions that model some human behavioural dimensions. This
original research paradigm allows us to build animal models offering good
face validity: extreme behaviours being assessed in rats are reminiscent of the
symptoms associated with human pathology. These models offer good
construct validity as they have been shown to rely on similar underlying
mechanisms. Finally, they have a good predictive validity, with respect to the
selectivity of responses to specific drugs and to environmental and temporal
challenges. Cross-species comparisons of behavioural traits can be made
using top-down or bottom-up approaches. A top-down perspective allows
us to examine in more details or to experimentally confirm what is already
observed in humans. A bottom-up perspective uses animal models to generate
hypotheses in humans, in a simplified and more controlled context [52]. The
experiments discussed here combine both kinds of approach.
From a developmental perspective, this paradigm is of major interest. It
has shed light on the impact of personality and behavioral traits on adaptive
resources and on the effects of early environmental exposure on personality
development as well. Finally, this approach can be extended to other kinds of
mental disorders, which opens new promising perspectives for the
understanding of psychopathologies. It is in line with dimensional views of
psychopathology assuming the absence of natural boundaries between mental
disorders and normality or health [62]. Even if there is a growing
22
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Adler, C.M., Holland, S.K., Schmithorst, V., Tuchfarber, M.J., Strakowski, S.M.,
2004, Bipolar Disord, 6, 540.
Adriani, W., Caprioli, A., Granstrem, O., Carli, M., Laviola, G., 2003, Neurosci
Biobehav Rev, 27, 639.
Antrop, I., Roeyers, H., Van Oost, P., Buysse, A., 2000, J Child Psychol
Psychiatry, 41, 225.
Aytaclar, S., Tarter, R.E., Kirisci, L., Lu, S., 1999, J Am Acad Child Adolesc
Psychiatry, 38, 172.
Baddeley, A.D., 1986, Working memory, Oxford University Press, Oxford.
Bardo, M.T., Donohew, R.L., Harrington, N.G., 1996, Behav Brain Res, 77, 23.
Barkley, R.A., 1997, Psychol Bull, 121, 65.
Barkley, R.A., 2001, Clin Psychol Sci Prac, 8, 498.
Barkley, R.A., 1977, J Child Psychol Psychiatry, 18, 137.
Barratt, E.S., 1981, Time perception, cortical evoked potentials and impulsiveness
among three groups of adolescents., Violence and violent individual.,J. Hays,
Roberts, T., Soloway, K. (Ed.), SP Medical Scientific, New York.
Barratt, E.S., Patton, J.H., 1983, Impulsivity: cognitive, behavioral and
psychophysiological correlates, Biological bases of sensation-seeking,
impulsivity, and anxiety,M. Zuckerman (Ed.), Lawrence Erlbaum Associates,
Hillsdale, NJ, 77.
Berger, D.F., Sagvolden, T., 1998, Behav Brain Res, 94, 73.
Bizot, J., Le Bihan, C., Puech, A.J., Hamon, M., Thiebot, M., 1999, Psychopharmacology (Berl), 146, 400.
Blondeau, C., 2004 U.F.R. des Sciences Mdicales, Universit Bordeaux 2 Victor
Segalen, Bordeaux, p. 198.
Blondeau, C., Dellu-Hagedorn, F., 2007, Biol Psychiatry, 61, 1340.
Bolden-Watson, C., Richelson, E., 1993, Life Sci, 52, 1023.
Chamberlain, S.R., Del Campo, N., Dowson, J., Muller, U., Clark, L., Robbins,
T.W., Sahakian, B.J., 2007, Biol Psychiatry, 62, 977.
Costa, P.T., Jr., McCrae, R.R., Arenberg, D., 1980, Journal of personality and
social psychology, 5, 793.
Daruna, J., Barnes, P., 1993, The impulsive client: theory, research and treatment.,
A neurodevelopmental view of impulsivity.,W. McCown, J. Johnson, M. Shure
(Eds.), American Psychological Association, Washington DC.
Deckel, A.W., Hesselbrock, V., 1996, Alcohol Clin Exp Res, 20, 1173.
Dellu-Hagedorn, F., 2006, Behav Brain Funct, 2, 10.
Dellu-Hagedorn, F., 2005, Neurobiol Learn Mem, 83, 43.
23
23. Dellu-Hagedorn, F., Grgoire, S., Le Moine, C., Rivalan, M., 2007 Society for
Neurosciences, San Diego.
24. Dellu-Hagedorn, F., Trunet, S., Simon, H., 2004, Neurobiol Aging, 25, 525.
25. Dellu, F., 1994 Biological and Medical Sciences - Neurosciences and
Pharmacology, Universit de Bordeaux 2, Bordeaux.
26. Dellu, F., Mayo, W., Piazza, P.V., Le Moal, M., Simon, H., 1993, Pers Individ
Dif, 14, 411.
27. Dellu, F., Mayo, W., Vallee, M., Le Moal, M., Simon, H., 1994, Brain Res, 653, 51.
28. Dellu, F., Mayo, W., Vallee, M., Maccari, S., Piazza, P.V., Le Moal, M., Simon,
H., 1996, Psychoneuroendocrinology, 21, 441.
29. Dellu, F., Piazza, P.V., Mayo, W., Le Moal, M., Simon, H., 1996,
Neuropsychobiology, 34, 136.
30. Dempster, F.N., Brainerd, C.J., 1995, Interference and inhibition in cognition.,
Academic Press, San Diego.
31. Desrichard, O., Denarie, V., 2005, Addict Behav, 30, 1449.
32. Deutch, A.Y., 1992, J Neural Transm Suppl, 36, 61.
33. Dinn, W.M., Harris, C.L., Aycicegi, A., Greene, P.B., Kirkley, S.M., Reilly, C.,
2004, Prog Neuropsychopharmacol Biol Psychiatry, 28, 329.
34. Disney, E.R., Elkins, I.J., McGue, M., Iacono, W.G., 1999, Am J Psychiatry, 156,
1515.
35. Domes, G., Winter, B., Schnell, K., Vohs, K., Fast, K., Herpertz, S.C., 2006,
Psychol Med, 36, 1163.
36. Donaldson, S., Goldstein, L.H., Landau, S., Raymont, V., Frangou, S., 2003, J
Clin Psychiatry, 64, 86.
37. Douglas, V.I., Parry, P.A., 1983, J Abnorm Child Psychol, 11, 313.
38. DSM-IV, 1994, American Psychiatric Association, Committee on Nomenclature
and Statistics: Diagnostic and Statistical Manual of Mental Disorders, American
Psychiatric Press, Washington, DC.
39. Evenden, J., 1999, J Psychopharmacol, 13, 180.
40. Evenden, J.L., 1998, Psychopharmacology (Berl), 138, 283.
41. Evenden, J.L., 1999, Psychopharmacology (Berl), 146, 348.
42. Evenden, J.L., Ryan, C.N., 1999, Psychopharmacology (Berl), 146, 413.
43. Evenden, J.L., Ryan, C.N., 1996, Psychopharmacology (Berl), 128, 161.
44. Eysenck, S.B.G., Pearson, P.R., Easting, G., Allsopp, J.F., 1985, Pers Individ Dif,
6, 613.
45. Ferster, C., Skinner, B., 1957, Schedules of reinforcement, Prentice-Hall,
Englewood Cliffs, NJ.
46. Finn, P., 2002, Behav Cogn Neurosci Rev, 1, 183.
47. Finn, P.R., Justus, A., Mazas, C., Steinmetz, J.E., 1999, Psychopharmacology
(Berl), 146, 465.
48. Garcia-Sevilla, L., 1984, Pers Individ Dif, 5, 511.
49. Goldman-Rakic, P.S., 1990, Prog Brain Res, 85, 325.
50. Goldman-Rakic, P.S., Muly, E.C., 3rd, Williams, G.V., 2000, Brain Res Brain
Res Rev, 31, 295.
24
51. Gosling, S., Kwan, V., John, O., 2003, Journal of personality and social
psychology, 85, 1161.
52. Gosling, S.D., 2001, Psychol Bull, 127, 45.
53. Green, S., 1983, Animal models in schizophrenia research., Animal models of
human behavior,G. Davey (Ed.), New York, 315.
54. Hata, T., Okaichi, H., 2004, Neurosci Res, 49, 81.
55. Hinshaw, S.P., 2001, Clin Psychol Sci Prac, 8, 498.
56. Ho, M.Y., Al-Zahrani, S.S., Al-Ruwaitea, A.S., Bradshaw, C.M., Szabadi, E.,
1998, J Psychopharmacol, 12, 68.
57. Ho, M.Y., Mobini, S., Chiang, T.J., Bradshaw, C.M., Szabadi, E., 1999,
Psychopharmacology (Berl), 146, 362.
58. Jentsch, J.D., Taylor, J.R., 1999, Psychopharmacology (Berl), 146, 373.
59. Jiang, H.K., Owyang, V.V., Hong, J.S., Gallagher, M., 1989, Proc Natl Acad Sci
U S A, 86, 2948.
60. Johansen, E.B., Sagvolden, T., 2004, Behav Brain Res, 149, 183.
61. Kabbaj, M., Devine, D.P., Savage, V.R., Akil, H., 2000, J Neurosci, 20, 6983.
62. Kendell, R., Jablensky, A., 2003, Am J Psychiatry, 160, 4.
63. Lahey, B.B., 2001, Clin Psychol Sci Prac, 8, 494.
64. Le Moal, M., Simon, H., 1991, Physiol Rev, 71, 155.
65. Lenzenweger, M.F., Clarkin, J.F., Fertuck, E.A., Kernberg, O.F., 2004, J
Personal Disord, 18, 421.
66. Lesieur, H.R., Rosenthal, R.J., 1991, J Gambl Stud, 7, 5.
67. Links, P.S., Heslegrave, R., van Reekum, R., 1999, J Personal Disord, 13, 1.
68. Logue, A.W., 1988, behav Brain Sci, 11, 665.
69. Marsh, P., Williams, L., 2004, Pers Individ Dif, 36, 1187.
70. McDonald, J., Schleifer, L., Richards, J.B., de Wit, H., 2003,
Neuropsychopharmacology, 28, 1356.
71. McGrath, J., Chapple, B., Wright, M., 2001, Acta Psychiatr Scand, 103, 181.
72. Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F.R.,
Spencer, T., 2001, Pediatrics, 108, E83.
73. Milich, R., Balentine, A.C., Lynam, D.R., 2001, Clin Psychol Sci Prac, 8, 463.
74. Mischel, 1966, Theory and research on the antecedents on self-imposed delay of
reward., Progress in experimental personality research,B.A. Maher (Ed.),
Academic Press, New York.
75. Moeller, F.G., Barratt, E.S., Dougherty, D.M., Schmitz, J.M., Swann, A.C., 2001,
Am J Psychiatry, 158, 1783.
76. Muir, J.L., Everitt, B.J., Robbins, T.W., 1996, Cereb Cortex, 6, 470.
77. Olson, S.L., Bates, J.E., Sandy, J.M., Schilling, E.M., 2002, J Child Psychol
Psychiatry, 43, 435.
78. Olson, S.L., Schilling, E.M., Bates, J.E., 1999, J Abnorm Child Psychol, 27, 151.
79. Ossmann, J.M., Mulligan, N.W., 2003, Am J Psychol, 116, 35.
80. Overall, K.L., 2000, Prog Neuropsychopharmacol Biol Psychiatry, 24, 727.
81. Pedinielli, J.L., Rouan, G., Bertagne, P., 1997, Psychopathologie des addictions,
Nodules PUF, Paris.
82. Pelham, W.E., 2001, Clin Psychol Sci Prac, 8, 502.
25
83. Peterson, J.B., Finn, P.R., Pihl, R.O., 1992, J Stud Alcohol, 53, 154.
84. Piazza, P.V., Deminiere, J.M., Le Moal, M., Simon, H., 1989, Science, 245, 1511.
85. Piazza, P.V., Maccari, S., Deminiere, J.M., Le Moal, M., Mormede, P., Simon,
H., 1991, Proc Natl Acad Sci U S A, 88, 2088.
86. Piazza, P.V., Rouge-Pont, F., Deminiere, J.M., Kharoubi, M., Le Moal, M.,
Simon, H., 1991, Brain Res, 567, 169.
87. Puumala, T., Sirvio, J., 1998, Neuroscience, 83, 489.
88. Pycock, C.J., Kerwin, R.W., Carter, C.J., 1980, Nature, 286, 74.
89. Rivalan, M., Gregoire, S., Dellu-Hagedorn, F., 2007, Psychopharmacology
(Berl), 192, 171.
90. Rouge-Pont, F., Deroche, V., Le Moal, M., Piazza, P.V., 1998, Eur J Neurosci,
10, 3903.
91. Rouge-Pont, F., Piazza, P.V., Kharouby, M., Le Moal, M., Simon, H., 1993,
Brain Res, 602, 169.
92. Rubia, K., 2002, Behav Brain Res, 130, 47.
93. Sagvolden, T., 2000, Neurosci Biobehav Rev, 24, 31.
94. Sagvolden, T., Aase, H., Zeiner, P., Berger, D., 1998, Behav Brain Res, 94, 61.
95. Sagvolden, T., Sergeant, J.A., 1998, Behav Brain Res, 94, 1.
96. Schaughency, E.A., Hynd, G.W., 1989, Learning and Individual Differences, 16,
54.
97. Sher, K.J., Trull, T.J., 2002, Curr Psychiatry Rep, 4, 25.
98. Siegman, A.W., 1961, J. Consult. Psychol., 25, 470.
99. Silver, L.B., 2000, Child Adolesc Psychiatr Clin N Am, 9, 511.
100. Sleator, E.K., Ullmann, R.K., 1981, Pediatrics, 67, 13.
101. Smith, W.J., 1965, American Naturalist, 99, 405.
102. Soubrie, P., 1986, J Pharmacol, 17, 107.
103. Spencer, T., Biederman, J., 2002, J Atten Disord, 6 Suppl 1, S109.
104. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., Griffin, S.,
1996, J Am Acad Child Adolesc Psychiatry, 35, 409.
105. Spencer, T.J., Biederman, J., Wilens, T.E., Faraone, S.V., 2002, J Clin
Psychiatry, 63 Suppl 12, 16.
106. Stevens, A., Burkhardt, M., Hautzinger, M., Schwarz, J., Unckel, C., 2004,
Psychiatry Res, 125, 257.
107. Sweeney, J.A., Kmiec, J.A., Kupfer, D.J., 2000, Biol Psychiatry, 48, 674.
108. Taylor, E., 1998, Behav Brain Res, 94, 11.
109. Thiebot, M.H., Le Bihan, C., Soubrie, P., Simon, P., 1985, Psychopharmacology,
86, 147.
110. Tripp, G., Alsop, B., 2001, J Child Psychol Psychiatry, 42, 691.
111. Tzschentke, T.M., 2001, Prog Neurobiol, 63, 241.
112. Villemarette-Pittman, N.R., Stanford, M.S., Greve, K.W., 2003, Pers Individ Dif,
34, 1533.
113. Visser, M., Das-Smaal, E., Kwakman, H., 1996, Br J Psychol, 87 (Pt 1), 131.
114. Vitacco, M.J., Rogers, R., 2001, J Am Acad Psychiatry Law, 29, 374.
115. Volkow, N.D., Fowler, J.S., 2000, Cereb Cortex, 10, 318.
116. Vornik, L.A., Brown, E.S., 2006, J Clin Psychiatry, 67 Suppl 7, 24.
26
117. Ward, J.H., 1963, Journal of the American Statistical Association, 58, 236.
118. Weinberger, D.R., Egan, M.F., Bertolino, A., Callicott, J.H., Mattay, V.S.,
Lipska, B.K., Berman, K.F., Goldberg, T.E., 2001, Biol Psychiatry, 50, 825.
119. Wender, P.H., Ward, M.F., Reimherr, F.W., Marchant, B.K., 2000, J Am Acad
Child Adolesc Psychiatry, 39, 543.
120. Whitney, P., Jameson, T., Hinson, J.M., 2004, Pers Individ Dif, 37, 417.
121. Wilens, T.E., 2004, Psychiatr Clin North Am, 27, 283.
122. Williams, D., Wells, P.A., Lowe, G., 1971, Nat New Biol, 232, 95.
123. Winstanley, C.A., Dalley, J.W., Theobald, D.E., Robbins, T.W., 2004,
Neuropsychopharmacology, 29, 1331.
124. Young, A.M., Moran, P.M., Joseph, M.H., 2005, Neurosci Biobehav Rev, 29,
963.
125. Young, S.E., Mikulich, S.K., Goodwin, M.B., Hardy, J., Martin, C.L., Zoccolillo,
M.S., Crowley, T.J., 1995, Drug Alcohol Depend, 37, 149.
126. Zentall, S.S., Meyer, M.J., 1987, J Abnorm Child Psychol, 15, 519.
127. Zentall, S.S., Zentall, T.R., 1983, Psychol Bull, 94, 446.
128. Zuckerman, L., 1994, Behavioural expressions and biosocial bases of sensationseeking., Cambridge.
129. Zuckerman, M., 1964, J. Consult. Psychol., 28, 477.
130. Zuckerman, M., 1993, Neuropsychobiology, 28, 30.
131. Zuckerman, M., 1991, Sensation seeking: the balance between risk and reward,
Self-regulatory behavior and risk-taking: causes and consequences.,L. Lipsitt, L.
Mitnick (Eds.), Ablex Publishing Corp., Norwood, NJ, 143.
132. Zuckerman, M., 1969, Theoretical formulations., Sensory deprivation: fifteen
years of research.,J.P. Zubek (Ed.), Appleton century, New York.
133. Zuckerman, M., Neeb, M., 1979, Psychiatry Res, 1, 255.